Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAPI-PET/MRI in Breast Carcinoma-In-Situ
NCT06540872Phase 2Recruiting
- Sponsor
- Universität Münster
- Start
- Feb 2026
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 68Ga FAPI-46 in ductal carcinoma in situ (DCIS), sponsored by Universität Münster. Started Feb 2026; status: recruiting.
02
Drugs
68Ga FAPI-46
03
Conditions
ductal carcinoma in situ (DCIS)
Beyond the preview
Go deeper on NCT06540872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06540872.